Carol Karp
General Counsel bei PROTHENA CORPORATION PLC
Vermögen: - $ am 31.05.2024
Aktive Positionen von Carol Karp
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PROTHENA CORPORATION PLC | General Counsel | 15.12.2016 | - |
| Rochester Christian University | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Carol Karp
Ehemalige bekannte Positionen von Carol Karp
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ESPERION THERAPEUTICS, INC. | Compliance Officer | 01.01.2013 | 01.01.2014 |
| General Counsel | 01.01.2013 | 01.01.2014 | |
| Janssen Alzheimer Immunotherapy | General Counsel | 01.01.2010 | 01.01.2013 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | General Counsel | - | 02.05.2011 |
| VIVUS, INC. | Corporate Officer/Principal | - | - |
| Powderject Technologies BV | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Carol Karp
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Niederlande | 2 |
| Irland | 2 |
Operativ
| General Counsel | 4 |
| Undergraduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
| Janssen Alzheimer Immunotherapy |
- Börse
- Insiders
- Carol Karp
- Erfahrung